Correlation Between Iovance Biotherapeutics and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Protalix Biotherapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Protalix Biotherapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Protalix Biotherapeutics
-0.91 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Iovance and Protalix is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Protalix Biotherapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Protalix Biotherapeutics. In addition to that, Iovance Biotherapeutics is 1.03 times more volatile than Protalix Biotherapeutics. It trades about -0.12 of its total potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.22 per unit of volatility. If you would invest 107.00 in Protalix Biotherapeutics on November 2, 2024 and sell it today you would earn a total of 131.00 from holding Protalix Biotherapeutics or generate 122.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Protalix Biotherapeutics |
Iovance Biotherapeutics and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Protalix Biotherapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |